In conclusion we may say the following:

1. Vaccinations modulate the immune system. What exactly happens lies beyond the capabilities of today's scientific analysis.

2. In particular, long-term consequences of vaccinations are unknown because their existence is difficult to prove statistically.

3. So-called minimal lesions [63] and their consequences are not included in statistical studies of vaccination-induced side effects.

4. Vaccinations do not give complete protection from the disease.

The decisive question one has to ask is whether the expected short-term benefit of vaccinations outweighs the potential long-term damage. We all tend to concern ourselves only with the problems at hand. Illnesses and diseases which threaten us now are more important in our eyes than possible complaints in the future. The fear of a post-measles encephalitis is bigger than the fear of the rheumatic pain of the 30 or 40 year old adult. If, however, there is indeed a connection between vaccinations and auto-immune diseases or tumor growth, it is questionable whether the cost-benefit analysis of today is still applicable. Considering that homeopathic treatment and prophylaxis can reduce the number of sequelae in childhood diseases significantly, the practice of vaccination becomes even more doubtful.

Knowledge of the nature of chronic diseases as described by Hahnemann are prone to make the homeopathic physician very skeptical towards introducing pathogens into the human body. (S. Hahnemann, Chronic Diseases, Theoretical Part)

Confirming Hahnemann's insights, the collective experiences of seasoned homeopathic physicians show that vaccinations pose an obstacle to cure, and that diseases frequently take their course after a vaccination. Furthermore, childhood diseases are usually managed easily, and unvaccinated children undergo a less complicated development than their vaccinated counterparts.

References

1. Howson, C.P., 1991, Adverse effects of Pertussis and Rubella Vaccines, National Academy Press, Washington, D.C.

2. Barnes, E.K., "Joint Reactions in children vaccinated against Rubella. Study II: Comparison of three vaccines," Am. J. Epidemiol., 1972; 95; pages 59-66.

3. Cooper, L.Z., "Transient Arthritis after Rubella Vaccination," Am. J. Dis. Child., 1969; 118; pages 218-25.

4. Horstmann, D.M., "Post-Partum Vaccination of Rubella-susceptible Women," Lancet, 1970; 2; pages 1003-6.

5. Lermann, S.J., "Immunologic response, virus excretion and joint reactions with rubella vaccine," Ann. Intern. Med., 1971; 74; pages 67-73

6. Spruance, S.L., "Joint complications associated with derivates of HPV-77 rubella virus vaccine," Am. J. Dis. Child., 1971; 122; pages 105-11.

7. Swartz, T.A., "Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine," Am. J. Epidemiol., 1971; 94; pages 246-51.

8. Thompson, G.R., "Acute arthritis complicating rubella vaccination," Arthritis Rheum., 1971; 14; pages 19-26

9. Wallace, R.B., "Joint symptoms following an area wide rubella immunization campaign: report of a survey," Am. J. Public Health, 1972; 62; pages 658-61.

10. Weibel, R.E., "Influence of age on clinical response to HPV 77 duck rubella vaccine," J.A.M.A., 1972; 222; pages 805-7.

11. Forsey, T., "Mumps vaccines-current status," J. Med. Microbiol., 1994; 41; pages 1-2.

12. Stratton, K.R., "Adverse events associated with childhood vaccines other than pertussis and rubella," J.A.M.A., May 25, 1994; 271, No. 20, pages 1602-1605

13. Forsey, T., "Mumps vaccines and meningitis," Lancet, 340, Oct. 17, 1992; page 980.

14. Gray, J.A., "Mumps meningitis following measles, mumps and rubella immunization," Lancet, July 8, 1989; page 98.

15. Morris, K., "Guillain Barre Syndrome after measles, mumps and rubella vaccine," Lancet, 343, Jan 1, 1994; page 60.

16. Miller, E., "Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children," Lancet, 341, April 17, 1993; pages 979-994.

17. Buskinco, L., "Measles, mumps, rubella immunization in egg-allergic children," Annals of Allergy, 72, Jan. 1994; pages 1-3.

18. Howson, C.P., "Chronic Arthritis after rubella vaccination," Clin. Inf. Dis., 15, 1992; pages 307-12.

19. Wyatt, H.V., "Vaccine associated poliomyelitis," Lancet, 343, March 5, 1994; pages 609-10.

20. Sutter, R.W., "Adverse Reaction to tetanus toxoid," J.A.M.A., 271, May 25, 1994; page 1629.

21. Zastrow, K.D., "Tetanus-Erkrankungen, Impfungen und Impfschäden in der Bundesrepublik Deutschland," 1971 bis 1990, Dtsch. med. Wschr., 118, 1993, pages 1617-1620.

22. Peltola, H., "Frequenzy of true adverse reactions to measles, mumps, rubella vaccine," Lancet, April 26, 1986; pages 939-942.

23. Kalden, J.R. and Gerth, H.J., "Polymyalgia rheumatica und Grippe Impfung," DMW 1992, 117; page 1259.

24. Forsey, T., "Mumps vaccines-current status," J. Med. Microbiol., 1994; 41; pages 1-2.

25. Gilsdorf, J.R., "Vaccines: Moving into the molecular era," J. Pediatr., Sept. 1994, 125; pages 339-44.

26. Ehrengut, W., "Komplikationen "nach" Mumpsschutzimpfungen in der Bundesrepublik Deutschland," Monatsschr. Kinderheilk, 1989, 137; pages 398-402.

27. Friedmann, A., "Oral Tolerance: A biologically relevant pathway to generate peripheral tolerance against external and self antigens," Chem. Immunol., 1994, 58; pages 259-290.

28. Rivera, E., "A new method for rapidly removing contaminating micro-organism from porcine parvo virus or pseudorabies virus master-seed suspensions," Vaccine, 1993, 11(3); pages 363-5.

29. Agocs, M.M., "The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure," Int. J. Epidemiol., 1992 Oct, 21 (5); pages 1007-13.

30. Brown, F., "Review of accidents caused by incomplete inactivation of viruses," Dev. Biol. Stand., 1993, 81 (1); pages 103-7.

31. Buchwald, G., 1994, Impfen- Das Geschäft mit der Angst, EMU, Verlag.

32. Clare, D., "Families win support for vaccine compensation claim," B.M.J., Vol. 309, 24. Sept. 1994; page 759.

33. Berr, C., "Risk factors in multiple sclerosis: A population based case-control study in Hautes-Pyrenees, France," Acta. Neurol. Scand. (Denmark), July 1989, 80 (1); pages 46-50.

34. White, P.M., "Prevalence of antibody to poliovirus in England and Wales," Br. Med. J., Nov. 1, 1986, 293 (6555); pages 1153-5.

35. Lasch, E.E., "Combined live inactivated poliovirus vaccine to control poliomyelitis in a developing country five years after," Dev. Biol. Stand., 1986, 65; pages 137-43.

36. Sutter, R.W., "Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral polio virus vaccine," Int. J. Epidemiol., Oct 1993, 22(5); pages 936-44.

37. Wyatt, H.V., "Unnecessary injections and paralytic poliomyelitis in India," Trans. R. Soc. Trop. Med. Hyg., Sept.-Oct. 1992, 86(5); pages 546-9.

38. Matson, D.O., "Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after re-vaccination," Pediatr. Infect. Dis. J., Apr. 1993, 12(4); pages 292-9.

39. Guimbao, B.J., "Parotitis in postvaccination period," Med. Clin., 1993 Apr. 10, 100(14); page 559.

40. Suarez, J., "Prevalence of anti-mumps IgG antibodies in a pediatric population," Enferm. Infecc. Microbiol. Clin., Mar. 1992, 10(3); pages 130-4.

41. Falk, W.A., "The epidemiology of mumps in southern Alberta 1980-82," Am. J. Epidemiol., Oct. 1989, 130(4); pages 736-49.

42. Arday, D.R., "Mumps in the US army 1980-86," Am. J. Public Health, Apr. 1989, 79(4); pages 471-4.

43. Wharton, M., "A large outbreak of Mumps in the postvaccine era," J. Infect. Dis., Dec. 1988, 158(6); pages 1253-60.

44. Agocs, M.M., "The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure," Int. J. Epidemiol., Oct. 1992, 21(5); pages 1007-13.

45. Carter, H., "Measles outbreak in Fife; which MMR Policy," Public Health, Jan. 1993, 107 (1); pages 25-30.

46. Marks, J.S., "Measles vaccine efficacy in children previously vaccinated at 12 month of age," Pediatrics, 1978, 62; pages 955-60.

47. Marks, J.S., "Measles outbreak in a vaccinated school population," A.J.P.H., 1987, 4; pages 434-38.

48. Hersh, B.S., "A measles outbreak at a college with prematriculation immunization requirement," Am, J, Public Health, 1991, 81; pages 360-64.

49. Daivis, R.M., "A persistent outbreak of measles despite appropriate prevention and control measures," Am. J. Epidemiol., 1987, 126; pages 438-49.

50. Hutchins, S.S., "A school-based measles outbreak," Am. J. Epidemiol., 1990, 132; pages 157-68.

51. Gustafson, T.L., "Measles outbreak in a fully immunized secondary-school population," New England Journal of Medicine, 1987, 316(13); pages 771-774.

52. Bendiner, E., "From Rabies to AIDS: 100 Years at Pasteur," Hosp. Pract., Nov. 30, 1987; pages 119-142.

53. Chakravarti, V.S. and Lingam, S., "Measles induced remission of psoriasis," Annals of Tropical Paediatrics, 1986, 6; pages 293-294

54. Rooth, I.B., "Suppression of plasmodium falciparum infections during measles or influenza," Am. J. Trop. Med. Hyg., Nov. 1992, 47(5); pages 675-81.

55. Rønne, T., "Measles virus infection without rash in childhood is related to disease in adult life," Lancet, Jan. 1985; pages 1-5.

56. Beale, A.J., "Hazards of vaccine production," FEMS Microbiol. Let., 1992, 100; pages 469-474.

57. Clarke, J.H., Praktische Materia Medica, 1994, S.1455

58. Brandis, H., Medizinische Mikrobiologie, 1994, S.268.

59. Barnett, L.A., "Molecular mimicry: a mechanism for autoimmune injury," FASEB J., Feb. 1, 1992; pages 840-4.

60. Roitt, I.M., Immunologie, 1991, S234ff.

61. Classen, Innere Medizin, 1994, S.464

62. Keller and Wiskott, Kinderheilkunde, 1991, S.380.

63. Coulter, H.., 1991, Dreifachimpfung, ein Schuß ins Dunkle,Barthel und Barthel, Verlag (translation of Coulter's A Shot in the Dark).

64. Kimman, T.G., "Risks connected with the use of conventional and genetically engineered vaccines," Veterinary Quarterly, Aug. 1992, Vol. 14(3); pages 110-118.